{
    "id": "5e766256835f4e4777000003",
    "question": "Have the rotavirus vaccines changed the predominant rotavirus genotypes?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "{\"step_by_step_thinking\": \"To answer this question, we need to consider the impact of rotavirus vaccines on the circulating rotavirus genotypes. Rotavirus vaccines are designed to protect against the most common strains of the virus. Before the introduction of rotavirus vaccines, the predominant rotavirus genotypes were predominantly G1P[8], G3P[8], and G4P[9].\\n\\nThe first rotavirus vaccine, Rotashield, was introduced in the US in 1998 and was primarily effective against the G1P[8] genotype. However, it was withdrawn from the market due to concerns about its safety.\\n\\nThe second rotavirus vaccine, Rotarix, was introduced in 2006 and was effective against the G1P[8] and G3P[8] genotypes. It also protected against the G4P[9] genotype, which was previously not targeted by the vaccine.\\n\\nThe third rotavirus vaccine, Rotarix was withdrawn from the US market in 2015 due to a higher incidence of intussusception. However, the vaccine is still widely used in many other countries.\\n\\nThe introduction of these vaccines has led to a decline in the circulation of the G1P[8] and G3P[8] genotypes, but the G4P[9] genotype is still present in many parts of the world.\\n\\nTherefore, the answer to the question is that the rotavirus vaccines have changed the predominant rotavirus genotypes, but the G4P[9] genotype remains a significant circulating genotype.\", \"answer_choice\": \"A\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 16.499767541885376
}